Serum pro‐inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti‐ VEGF : association with intravitreal injection treatment profiles in real‐world setting-Reference-Cited by-同舟云学术

Serum pro‐inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti‐ VEGF : association with intravitreal injection treatment profiles in real‐world setting

Published:2019-11-19 Issue:4 Volume:98 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Brito Pedro¹^ORCID,Costa Jorge¹,Gomes Nuno¹,Costa Sandra²³,Correia‐Pinto Jorge²³,Silva Rufino⁴⁵⁶

Affiliation:

1. Opthalmology Department Hospital de Braga Braga Portugal

2. Life and Health Sciences Research Institute (ICVS) School of Medicine University of Minho, Campus Gualtar Braga Portugal

3. ICVS/3B's – PT Government Associate Laboratory Braga/Guimarães Portugal

4. Department of Ophthalmology Centro Hospitalar e Universitario de Coimbra (CHUC) Coimbra Portugal

5. Faculty of Medicine Coimbra Institute for Clinical and Biomedical Research University of Coimbra (iCBR‐ FMUC) Coimbra Portugal

6. Association for Innovation and Biomedical Research on Light and Image (AIBILI) Coimbra Portugal

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14308

Reference36 articles.

1. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

2. Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

3. Factors Associated With Changes in Visual Acuity and Central Subfield Thickness at 1 Year After Treatment for Diabetic Macular Edema With Ranibizumab

4. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment

5. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergic effects of Trigonella foenum-graecum, Ribes rubrum, Lavandula angustifolia, and Arctium Lappa extracts mixture on learning and memory deficits in streptozocin-induced diabetic rats;IRAN J BASIC MED SCI;2023

2. Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods;Survey of Ophthalmology;2023-03

3. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema;Seminars in Ophthalmology;2022-04-25

4. Monoclonal antibodies in diabetic retinopathy;Expert Review of Clinical Immunology;2022-02-01